3 hours Day One Biopharmaceuticals (NASDAQ:DAWN) Given New $33.00 Price Target at Needham & Company LLC MarketBeat
Needham & Company LLC boosted their price objective on shares of Day One Biopharmaceuticals from $32.00 to $33.00 and gave the company a “buy” rating in a research report on Wednesday.